NeuroPace (NPCE) Other Non-Current Assets (2020 - 2026)
NeuroPace (NPCE) posted quarterly Other Non-Current Assets of $852000.0 for Q1 2026, up 598.36% year-over-year from $122000.0 in Q1 2025, and up 598.36% quarter-over-quarter from $122000.0 in Q4 2025.
NeuroPace (NPCE) Other Non-Current Assets (2020 - 2026) Analysis & Trends
NeuroPace's Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $852000.0 for Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 598.36% year-over-year to $852000.0; the TTM figure through Mar 2026 stood at $852000.0 (up 598.36% YoY), while the FY2025 annual figure was $122000.0, changed 0.0% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $852000.0, up from $122000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $852000.0 in Q1 2026, with the low at $87000.0 in Q2 2025.
- The 5-year median for Other Non-Current Assets is $122000.0 (2022), against an average of $162764.7.
- The sharpest annual moves came in 2022 and 2026: Other Non-Current Assets sank 66.67% in 2022, then soared 598.36% in 2026.
- NeuroPace's Other Non-Current Assets stood at $122000.0 in 2022, then changed by 0.0% to $122000.0 in 2023, then changed by 0.0% to $122000.0 in 2024, then changed by 0.0% to $122000.0 in 2025, then jumped by 598.36% to $852000.0 in 2026.
- Business Quant data shows NPCE's Other Non-Current Assets at $852000.0 in Q1 2026, $122000.0 in Q4 2025, and $120000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 215.10 Mn |
| 10 | NeuroPace | 478.49 Mn | 426.79 Mn | 18.91 Mn | 241,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 241,000.00 |
| Mar 31, 2026 | 852,000.00 |
| Dec 31, 2025 | 122,000.00 |
| Sep 30, 2025 | 120,000.00 |
| Jun 30, 2025 | 87,000.00 |
| Mar 31, 2025 | 122,000.00 |
| Dec 31, 2024 | 122,000.00 |
| Sep 30, 2024 | 122,000.00 |
| Jun 30, 2024 | 122,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Dec 31, 2023 | 122,000.00 |
| Sep 30, 2023 | 122,000.00 |
| Jun 30, 2023 | 122,000.00 |
| Mar 31, 2023 | 122,000.00 |
| Dec 31, 2022 | 122,000.00 |
| Sep 30, 2022 | 122,000.00 |
| Jun 30, 2022 | 122,000.00 |
| Mar 31, 2022 | 122,000.00 |
| Dec 31, 2021 | 122,000.00 |
| Sep 30, 2021 | 122,000.00 |